Skin and hair Clinical Trials: Active Studies by Market and Country

• 23markets with active trials
• 4,813active studies on Dermatology Diagnostic
• 38of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Dermatology Diagnostic4,813Dermatology Diagnostic: See them on ClinicalTrials.gov (opens in a new tab)
2. 2Psoriasis Treatment412Psoriasis Treatment: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Atopic Dermatitis Treatment344Atopic Dermatitis Treatment: See them on ClinicalTrials.gov (opens in a new tab)
4. 4Atopic Dermatitis Drugs342Atopic Dermatitis Drugs: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Alopecia Drugs (Hair Loss)185Alopecia Drugs (Hair Loss): See them on ClinicalTrials.gov (opens in a new tab)
6. 6Alopecia Treatment183Alopecia Treatment: See them on ClinicalTrials.gov (opens in a new tab)
7. 7Alopecia areata177Alopecia areata: See them on ClinicalTrials.gov (opens in a new tab)
8. 8Aesthetic Lasers and Energy Devices134Aesthetic Lasers and Energy Devices: See them on ClinicalTrials.gov (opens in a new tab)
9. 9Collagen Supplements131Collagen Supplements: See them on ClinicalTrials.gov (opens in a new tab)
10. 10Acne Treatment129Acne Treatment: See them on ClinicalTrials.gov (opens in a new tab)
11. 11Hidradenitis Suppurativa Treatment101Hidradenitis Suppurativa Treatment: See them on ClinicalTrials.gov (opens in a new tab)
12. 12Vitiligo Treatment99Vitiligo Treatment: See them on ClinicalTrials.gov (opens in a new tab)
13. 13Chronic Urticaria Treatment60Chronic Urticaria Treatment: See them on ClinicalTrials.gov (opens in a new tab)
14. 14Artificial Skin34Artificial Skin: See them on ClinicalTrials.gov (opens in a new tab)
15. 15Biotin Supplement32Biotin Supplement: See them on ClinicalTrials.gov (opens in a new tab)
16. 16Cutaneous Leishmaniasis18Cutaneous Leishmaniasis: See them on ClinicalTrials.gov (opens in a new tab)
17. 17Over The Counter (OTC) Antifungal16Over The Counter (OTC) Antifungal: See them on ClinicalTrials.gov (opens in a new tab)
18. 18Leprosy12Leprosy: See them on ClinicalTrials.gov (opens in a new tab)
19. 19Scabies8Scabies: See them on ClinicalTrials.gov (opens in a new tab)
20. 20Yaws5Yaws: See them on ClinicalTrials.gov (opens in a new tab)
21. 21Buruli Ulcer3Buruli Ulcer: See them on ClinicalTrials.gov (opens in a new tab)
22. 22Skin NTDs2Skin NTDs: See them on ClinicalTrials.gov (opens in a new tab)
23. 23Regenerative Aesthetics1Regenerative Aesthetics: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

  NCT07619534Dermatology Diagnostic

• Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

  NCT06260033Dermatology Diagnostic

• Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

  NCT07217990Dermatology Diagnostic

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  NCT03816345Psoriasis Treatment

• A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  NCT06671483Psoriasis Treatment

• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

  NCT04751396Psoriasis Treatment

• Study of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe Eczema

  NCT07932795Atopic Dermatitis Treatment

• A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

  NCT06807268Atopic Dermatitis Treatment

• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  NCT07765888Atopic Dermatitis Treatment

• Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

  NCT07262983Atopic Dermatitis Drugs

• Role of Interleukin-13 Pathways on Pain and Itch Sensitivity

  NCT06503510Atopic Dermatitis Drugs

• Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  NCT07645820Atopic Dermatitis Drugs

• Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia

  NCT07806474Alopecia Drugs (Hair Loss)

• Comparative Effectiveness of Intralesional Injection of Triamcinolone Acetonide vs. Microneedling With Local Application of Triamcinolone Acetonide in the Treatment of Alopecia Areata

  NCT07926711Alopecia Drugs (Hair Loss)

• Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

  NCT06531109Alopecia Drugs (Hair Loss)

• Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir and Topical 5% Minoxidil

  NCT07901426Alopecia Treatment

• Study to Evaluate Xtressé Gummy Supplement in Women With Thinning Hair

  NCT07919782Alopecia Treatment

• Effectiveness and Safety of Cellbooster Hair in Healthy Subjects

  NCT07929857Alopecia Treatment

• A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

  NCT07214272Aesthetic Lasers and Energy Devices

• Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias

  NCT07793630Aesthetic Lasers and Energy Devices

• A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

  NCT07187297Aesthetic Lasers and Energy Devices

• Effect of Collagen and MSM Supplementation on Advanced Glycation End Products in Skin: Part B of the TO-COSKIN4 Study

  NCT07925437Collagen Supplements

• A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07288138Collagen Supplements

• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

  NCT04526665Collagen Supplements

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Aesthetics
• Infectious diseases
• Nutrition
• Allergies
• Biologics and biosimilars
• Immune health
• Autoimmune diseases
• Artificial intelligence
• Diagnostics and lab testing
• Digital health